NCT06284525

Ankle Assistance and Resistance in Older Adults

Name: Clinical Trial NCT06284525
Creator: Northern Arizona University
Keywords: Sarcopenia, Ankle resistance and biofeedback, Phase 1, device, clinical trial, United States of America

Northern Arizona University·Phase 1·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Sarcopenia
Drug/Device/Intervention: Ankle resistance and biofeedback
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Northern Arizona University
Location: Flagstaff, United States of America

Timeline & enrollment

Phase: Phase 1
Start date: Feb 01, 2023
End date: Jan 01, 2025
Enrollment: 8 participants

Primary outcome

6MWT,Metabolic power,Plantar flexor strength

Summary

The goal of this research protocol is to improve mobility in older individuals through advances in wearable assistive devices by focusing on two specific aims. The first aim is to study if targeted ankle resistance gait training improves walking performance in older individuals. The second aim is to evaluate the potential of wearable assistance at the ankle, knee, and/or hip joints to increase walking performance in older individuals.

ICD-10 classifications

Kaposi sarcomaHerniaTaeniasisTaenia saginata taeniasisDiaphragmatic hernia

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06284525
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06284525 through Pure Global AI's free database. This Phase 1 trial is sponsored by Northern Arizona University and is currently Recruiting. The study focuses on Sarcopenia. Target enrollment is 8 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.